Trusted Business Insights presents the Latest Study on Rabies Diagnostics Market 2019-2025. The report contains market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments of the market. It also examines the role of the leading market players involved in the industry including their corporate overview, financial summary, and SWOT analysis.
Get Sample Copy of this Report @ Rabies Diagnostics Market Size & Share, Sector / Industry Report & Analysis, 2019-2025
Abstract, Snapshot, Market Analysis & Market Definition: Global Rabies Diagnostics Market
The global rabies diagnostics market size was valued at USD 1.47 billion in 2017 and is projected to expand at a CAGR of 4.1% during the forecast period. Neglected Tropical Diseases (NTDs) have afflicted several densely populated and low-resource setting regions across the globe. One such NTD is Rabies that continues to pose a significant threat to human and animal health, particularly in Asian and African countries.
Several international healthcare organizations are engaged in establishing collaboration with healthcare entities for development and commercialization of novel detection assays to drive the efforts that target to combat the disease. For example, the World Health Organization (WHO), in collaboration with other healthcare agencies, such as provincial health authorities, is involved in the promotion of research endeavors taken up for rabies control across the globe. The WHO has also released several documents illustrating various aspects of a comprehensive control program for this disease. Such ongoing activities in the rabies testing market are anticipated to fuel the demand for robust diagnostic solutions.
Currently most of the commercial tests are based on antemortem diagnosis of human rabies virus. The tests are available across various ranges in context to cost and efficiency. National laboratories prefer internationally recommended tests which employ validated reagents and equipment for virus detection.
On the contrary, smaller and remote provincial laboratories deploy simpler conventional chemical stain tests that cost low. However, the accuracy associated with the use of this test is significantly low. In such cases, the sample that gives negative results at a provincial laboratory is transported to a national laboratory for re-testing.
This, in turn, poses challenges pertaining to additional cost requirement and delay in effective control of infection. These challenges have spurred the development of novel solutions to meet the unmet demand of population, physicians, and entities involved in control programs.
For example, in 2018, LN34 pan-lyssavirus real-time RT-PCR assay was evaluated for its efficiency in post-mortem rabies diagnostics. This LN34 test is considered to be simpler and easier to use. Similarly, in 2017, Rabies Immunoperoxidase Antigen Detection (RIAD) test was developed in Indonesia as a cost-effective and accurate solution. Development of novel tests aimed at improving disease testing in the resource-poor countries as well as developed nations, is projected to drive awareness and adoption.
Market Segmentation, Outlook & Viewpoint: Global Rabies Diagnostics Market
Diagnostic Method Market Segmentation & Outlook (Revenue, USD Million, 2014 – 2025)
Fluorescent Antibody Test (FAT)
Technology Method Market Segmentation & Outlook (Revenue, USD Million, 2014 – 2025)
Key Players, Recent Developments & Regional Insights: Global Rabies Diagnostics Market
Are you working or have business association with any of the below-listed market leaders? If Yes, Request any ONE of your Competitor Data for free here. *T&C Apply*
ELISA/Immunohistochemistry accounted for the largest market share owing to the higher penetration of products based on ELISA/immunohistochemistry protocols. Various test methods that are based on this technology include FAT, RREID, dRIT, RIDT, and IRIT. Immunohistochemistry based methods offer significant advantages that have led to the high adoption of this technology, which in turn is projected to propel the segment growth in the forthcoming years.
Some advantages associated with immunohistochemistry-based methods include cost-effectiveness, relative ease of interpretation using an ordinary light microscope, and less time consumption. Moreover, IHC-based assays are applicable on the frozen and preserved samples thus increasing the adoption rate.
PCR-based methods are expected to witness the fastest growth during the forecast period owing to their capability of performing both antemortem and postmortem rabies testing. Furthermore, real-time PCR based assays are considered as a universal real-time assay for testing of Lyssaviruses.
Rabies occurrence is observed in more than a hundred and fifty countries and territories, but the dominance is marked in Asia and Africa. As per the WHO, annually 31,000 human deaths occur due to rabies in Asia. It also states that over 2,000 deaths are reported each year since a decade in China, which is lesser than those observed in India. These data and statistics have pronounced the need for several control programs thus driving the market growth in the forthcoming years.
Furthermore, U.S. market is anticipated to grow significantly throughout the forecast period, owing to the substantial use of diagnostic tests in the country. The Centers for Disease Control and Prevention (CDC) states that more than 120,000 animals are tested for rabies annually in U.S.
Several diagnostic entities operate in the country, contributing to the increasing revenue share. On the other hand, in Europe, most of the countries are declared rabies free. Nevertheless, as per the veterinary records; U.K. faced re-emergence of the disease from 2000, whereas the country was designated as rabies-free in 1902.
Rabies Diagnostics Market Share Insights
Some key companies operating in this market include Bio-Rad Laboratories, Inc.; Aviva Systems Biology Corporation; Merck KGaA; Demeditec Diagnostics GmbH; Creative Diagnostics; Norgen Biotek Corp.; Abbexa Ltd.; Express Biotech International Inc.; BioNote, Inc.; and MyBioSource.com.
These companies engage in collaborations with healthcare organizations aiming to eliminate the disease through vaccination programs. They provide diagnostic tools required during mapping prevalence, monitoring impact of the Mass Drug Administration (MDA) program, reducing MDA, and post-elimination surveillance.
Some companies engage in the development of products for diagnostic purposes, whereas some focus only on product development for research purposes. For example, Abbexa Ltd develops and markets product only for research.
Key Insights Covered: Global Rabies Diagnostics Market
1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Rabies Diagnostics industry.
2. Global major manufacturers’ operating situation (sales, revenue, growth rate and gross margin) of Rabies Diagnostics industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Rabies Diagnostics industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Rabies Diagnostics industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Rabies Diagnostics industry.
Research Methodology: Global Rabies Diagnostics Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other
Quick Read Table of Contents of this Report @ Rabies Diagnostics Market Size & Share, Sector / Industry Report & Analysis, 2019-2025
Trusted Business Insights
Media & Marketing Executive
Email Me For Any Clarifications
US: +1 646 568 9797
UK: +44 330 808 0580
This post was originally published on Analytics News